News

CardioInsight Technologies Inc.’s Ecvue system will be featured at the Rhythm Theatre Symposium and in 17 abstract presentations at the upcoming 2014 Heart Rhythm Society Annual Scientific...

Gore Tag Thoracic Branch Endoprosthesis LSA Feasibility Study Clinical Trial

W. L. Gore & Associates (Gore) announced that Himanshu Patel, M.D. and David Williams, M.D. at The University of Michigan enrolled the first patient in the Gore TAG Thoracic Branch...

FDA MSC Consortium Stem Cell Research

The U.S. Food and Drug Administration (FDA) MSC Consortium is a large team of FDA scientists studying adult mesenchymal stem cells (MSCs), which could eventually be used to repair, replace,...

The American Society of Echocardiography (ASE) exhibited at the American College of Physicians’ (ACP) Internal Medicine 2014 meeting in early April as part of the society’s efforts to spread the...

Late-Breaking Trials SCAI May 2014

The Society for Cardiovascular Angiography and Interventions (SCAI) announced the late-breaking clinic al trial data presentations for it its upcoming 2014 Scientific Sessions, May 28-31, in Las...

May 2, 2014 — Medtronic Inc. revealed new data demonstrating positive outcomes for extreme risk patients with severe aortic stenosis who were treated with the CoreValve system via alternative...

May 2, 2014 — Terso Solutions Inc., a provider of automated inventory management solutions for healthcare and life science, announced that Endologix Inc. has partnered with them for a fully...

May 1, 2014 — Government regulations and JCAHO (Joint Commission) certification are driving providers to make purchasing plans for dose monitoring solutions, and in discussions about these plans,...

May 1, 2014 — Nuance Communications announced the immediate availability of the Nuance PowerShare network, the industry’s largest cloud-based network for securely connecting healthcare...

Boston Scientific Promus Premier Drug Eluting Stent

Boston Scientific Corp. has launched the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan. This advanced drug-eluting stent (DES) technology system recently...

Volcano Corp. announced the commencement of its limited market release of its U.S. Food and Drug Administration (FDA) cleared and CE marked technology SyncVision, with cases being performed in the...

It is impossible to escape the reality that as the use of mobile electronic devices increases amongst consumers, a proportionate increase in the use of such devices in the medical sales and...

CVIS, cardiovascular information system

A successfully implemented CVIS solution allows your organization to modernize and optimize the cardiovascular service line. Breaking down the advantages into terms and next steps you can discuss...

Imris Visius iMR Tampa General Hospital

Imris Inc. announced that a University of South Florida neurosurgical team at Tampa General Hospital (TGH) completed initial cases using its recently installed Visius intraoperative MRI (...

April 30, 2014 — Fovia Medical Inc. and Imperial College London, a science-based institution in biomedical research, announced a collaboration to bring High Definition Volume Rendering (HDVR) to...

NIH Cardiac Diagnostics Genetic Disorder Strokes Vascular Inflammation Children

National Institutes of Health (NIH) researchers have identified gene variants that cause a rare syndrome of sporadic fevers, skin rashes and recurring strokes, beginning early in childhood.

Nanostim Leadless Pacemaker Scripps Health Implant

Scripps Health became the first health care provider in Southern California to implant the investigational Nanostim leadless pacemaker, the world's first wireless pacemaker totally implanted...

April 30, 2014 — Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a new ultrasound device that could help identify arterial...

April 30, 2014 — Celladon Corp. announced its lead product candidate, Mydicar, has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA) for reducing...

April 29, 2014 — Armetheon Inc. announced it has reached agreement with the U.S. Food and Drug Administration (FDA) on a special protocol assessment (SPA) for the final pivotal trial of tecarfarin...